Numerous studies indicate that activating the PKA/p-CREB/BDNF pathway can inhibit the apoptosis of dopaminergic neurons, thereby improving behavioral deficits associated with PD [13,14]. The gene discussed is CREB1; the disease is Parkinson disease.